Pulmonary exposure to silver nanoparticles (AgNPs) revealed the potential of nanoparticles
to cause pulmonary toxicity, cross the alveolar-capillary barrier, and distribute to remote …

Silver nanoparticles (AgNPs) are the most commonly used nanoparticles (NPs) owing to
their anti-microbial properties, and the pulmonary system provides a major portal of entry for …

With advent of nanotechnology, silver nanoparticles, AgNPs owing majorly to their
antibacterial properties, are used widely in food industry and biomedical applications …

The health effects of silver nanoparticles (AgNPs) have not been well investigated, despite
AgNPs now being widely used in consumer products. We investigated the metabolic …

Exposure to wet aerosols generated during use of spray products containing silver (Ag) has
not been evaluated. The goal was to assess the potential for cardiopulmonary toxicity …

Silver nanoparticles are widely used in various industrial and biomedical applications;
however, little is known about their potential cardiotoxicity after pulmonary exposure …

To study the acute and subacute pulmonary toxicity of colloidal silver nanoparticles (Ag-
NPs), 0 or 100 ppm of Ag-NPs were instilled intratracheally in mice. Cellular and …

Silver nanoparticles (AgNP), with their important properties, are being used in a range of
sectors from industry to medicine, leading to increased human exposure. Hence, their …

The respiratory tract is the route of entry for accidentally inhaled AgNPs, which can reach the
lungs and redistribute to other main organs through systemic circulation. In the present work …

Particle size and surface chemistry are potential determinants of silver nanoparticle (AgNP)
respiratory toxicity that may also depend on the lung inflammatory state. We compared the …